Type
Business expansion
Country
France
Region
Nord - Pas-De-Calais; Nord;
Location of affected unit(s)
Saint-Amand-les-Eaux
Sector
Manufacturing
Manufacture Of Chemicals And Pharamceuticals
Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations
21.20 - Manufacture of pharmaceutical preparations

100 jobs
Number of planned job creations
Job creation
Announcement Date
18 July 2020
Employment effect (start)
22 July 2020
Foreseen end date
31 December 2020

Description

The pharmaceutical giant GSK has announced 100 recruitments for its Saint-Amand-les-Eaux (Nord) plant, which produces vaccines and could manufacture one or more vaccines against COVID-19. 80% of the new employees are operators, but also technicians, supervisors and maintenance staff.  The site produces some 20 vaccines for 120 countries, for children and adults, notably against malaria and meningitis. Without waiting for this new vaccine against COVID-19, the crisis has already had positive effects for the pharmaceutical giant, says the establishement's director. Indeed, the health crisis has really highlighted the importance of vaccines, and then the need to ensure the continuity of supply of these vaccines.

The plant, which has doubled its workforce since its creation in 2011, currently employs 900 people.


Sources

Citation

Eurofound (2020), GlaxoSmithKline Biologicals, Business expansion in France, factsheet number 101298, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/101298.